Clinical Trials in Baltimore

Showing 14441-14460 of 20,142 trials

Prevention of Alcohol Intolerance

NCT01845220

This study is designed to determine whether Asians who are especially sensitive to alcohol exposure can be protected by boosting their activities of an alcohol disposing enzyme. This will be accomplished by administering broccoli sprouts that are rich in an agent that increases protective enzyme activity. The test system involves applying alcohol patches to the skin and measuring skin redness.

Alcohol Sensitivity

Johns Hopkins University30 participantsStarted Apr 2014

Baltimore, Maryland, United States

COMPLETEDPhase 2< 1 mile

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma

NCT00242996

RATIONALE: Giving colony-stimulating factors, such as G-CSF, monoclonal antibodies, such as rituximab, and chemotherapy, such as cyclophosphamide, helps stem cells move from the patient's bone marrow to the blood so they can be collected and stored for peripheral stem cell transplant. Giving chemotherapy, such as carmustine, etoposide, and cyclophosphamide, before transplant stops the growth of cancer cells by stopping them from dividing or killing them. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. More rituximab is given after transplant to kill any remaining cancer cells. PURPOSE: This phase II trial is studying how well giving rituximab together with cyclophosphamide and G-CSF followed by combination chemotherapy works in treating patients undergoing an autologous stem cell transplant followed by rituximab and GM-CSF for refractory diffuse large B-cell lymphoma.

Lymphoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 participantsStarted Mar 2004

Baltimore, Maryland, United States

Prevention of Alcohol Intolerance

Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma

Find Trials by Condition in Baltimore

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Pazopanib Hydrochloride in Treating Patients With Advanced or Progressive Malignant Pheochromocytoma or Paraganglioma

Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Evaluation of the Heparin Binding Protein Levels in Sepsis

Oral Rivaroxaban in Children With Venous Thrombosis

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Physiologic Definition of Bronchopulmonary Dysplasia

Delayed Cord Clamping in VLBW Infants

Ispinesib In Combination With Carboplatin In Patients With Solid Tumors

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD